377 related articles for article (PubMed ID: 16537810)
21. Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.
Hu W; Jain A; Gao Y; Dozmorov IM; Mandraju R; Wakeland EK; Pasare C
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13994-9. PubMed ID: 26508631
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.
Breckpot K; Escors D; Arce F; Lopes L; Karwacz K; Van Lint S; Keyaerts M; Collins M
J Virol; 2010 Jun; 84(11):5627-36. PubMed ID: 20237085
[TBL] [Abstract][Full Text] [Related]
23. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy.
Krummen M; Balkow S; Shen L; Heinz S; Loquai C; Probst HC; Grabbe S
J Leukoc Biol; 2010 Jul; 88(1):189-99. PubMed ID: 20360404
[TBL] [Abstract][Full Text] [Related]
24. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
25. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation.
Hoshino K; Kaisho T; Iwabe T; Takeuchi O; Akira S
Int Immunol; 2002 Oct; 14(10):1225-31. PubMed ID: 12356687
[TBL] [Abstract][Full Text] [Related]
26. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
[TBL] [Abstract][Full Text] [Related]
27. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
Querec T; Bennouna S; Alkan S; Laouar Y; Gorden K; Flavell R; Akira S; Ahmed R; Pulendran B
J Exp Med; 2006 Feb; 203(2):413-24. PubMed ID: 16461338
[TBL] [Abstract][Full Text] [Related]
28. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
29. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.
Boonstra A; Rajsbaum R; Holman M; Marques R; Asselin-Paturel C; Pereira JP; Bates EE; Akira S; Vieira P; Liu YJ; Trinchieri G; O'Garra A
J Immunol; 2006 Dec; 177(11):7551-8. PubMed ID: 17114424
[TBL] [Abstract][Full Text] [Related]
30. Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo.
Wurzenberger C; Koelzer VH; Schreiber S; Anz D; Vollmar AM; Schnurr M; Endres S; Bourquin C
Cancer Immunol Immunother; 2009 Jun; 58(6):901-13. PubMed ID: 18953536
[TBL] [Abstract][Full Text] [Related]
31. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
32. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor 7 controls the anti-retroviral germinal center response.
Browne EP
PLoS Pathog; 2011 Oct; 7(10):e1002293. PubMed ID: 21998589
[TBL] [Abstract][Full Text] [Related]
34. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
35. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes.
Fujimoto C; Nakagawa Y; Ohara K; Takahashi H
Int Immunol; 2004 Jan; 16(1):55-63. PubMed ID: 14688061
[TBL] [Abstract][Full Text] [Related]
36. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
[TBL] [Abstract][Full Text] [Related]
37. CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells.
Lichtenegger FS; Mueller K; Otte B; Beck B; Hiddemann W; Schendel DJ; Subklewe M
PLoS One; 2012; 7(9):e44266. PubMed ID: 22962607
[TBL] [Abstract][Full Text] [Related]
38. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
39. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Yang R; Murillo FM; Cui H; Blosser R; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Virol; 2004 Oct; 78(20):11152-60. PubMed ID: 15452235
[TBL] [Abstract][Full Text] [Related]
40. Rapid Downregulation of DAB2 by Toll-Like Receptor Activation Contributes to a Pro-Inflammatory Switch in Activated Dendritic Cells.
Figliuolo da Paz V; Jamwal DR; Gurney M; Midura-Kiela M; Harrison CA; Cox C; Wilson JM; Ghishan FK; Kiela PR
Front Immunol; 2019; 10():304. PubMed ID: 30873168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
